Laudanski et al. showed that TP53 mutations and p53 overexpression were significantly correlated with poor survival in NSCLC; however, in a multivariate analysis, only the presence of TP53 mutations remained an independent, significant unfavourable prognostic factor for survival [15]. This evidence concerns the gene TP53 and non-small cell lung carcinoma.